Trial site
Swedish Cancer Insitute
- 1running trial
- 0closed trials
- 0trials confirmed by the site in the last 60 days
- –languages not stated
No trial has been confirmed here yet.
Running trials
Active, not recruiting
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
Researchers
No researcher is linked here yet.
Site data: ClinicalTrials.govUpdated 3 Nov 2026